|
| 1 |
Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
Masaya Uno, Rie Matsuo, Naoki Maezawa, Tomoyasu Kato
Obstet Gynecol Sci.2023;66(4):290-299. Published online 2023 July 15
DOI: http://dx.doi.org/10.5468/ogs.23024
|
|
| 2 |
Rehmannioside D mitigates disease progression in rats with experimental-induced diminished ovarian reserve via Forkhead Box O1/KLOTHO axis
Yan Liang, Huimin Wang, Jin Chen, Lingyan Chen, Xiaoyong Chen
|
|
| 3 |
Premenarchal ovarian torsion
Wesley Eilbert, Henry Nguyen
|
|
| 4 |
Gonadal Function in Female Adolescent and Young Adult Survivors of Childhood Cancer
Hye Young Jin, Jun Ah Lee, Meerim Park, Hyeon Jin Park
Cancer Res Treat.2023;55(3):992-1000. Published online 2023 January 31
DOI: http://dx.doi.org/10.4143/crt.2022.1518
|
|
| 5 |
GBA inhibition suppresses ovarian cancer growth, survival and receptor tyrosine kinase AXL-mediated signaling pathways
Gang Wang, Baisha Ouyang, Fang Jing, Xiaoyan Dai
|
|
| 6 |
Characterization of a conjugated polysuccinimide-carboplatin compound
Sun Young Lee, Chang Hoon Chae, Miklós Zrínyi, Xiangguo Che, Je Yong Choi, Dong-Hyu Cho
|
|
| 7 |
Beneficial effects of Teucrium polium hydroalcoholic extract on letrozole-induced polycystic ovary syndrome in rat model
Zeynab Khosrowpour, Shirin Fahimi, Fateme Jafari, Mojgan Tansaz, Shamim Sahranavard, Mehrdad Faizi
Obstet Gynecol Sci.2023;66(2):107-117. Published online 2022 December 28
DOI: http://dx.doi.org/10.5468/ogs.22129
|
|
| 8 |
Comprehensive clinical characterization of patients with BRCA1: c.5017_5019del germline variant
Yoon Ju Bang, Won Kyung Kwon, Jong-Won Kim, Jeong Eon Lee, Boo Yeon Jung, Mina Kim, Jisun Kim, Jeongshin An, Seung Pil Jung, Hong-Kyu Kim, Zisun Kim, Hyun Jo Youn, Jai Min Ryu, Sung-Won Kim,
|
|
| 9 |
Age at Menopause and Suicidal Ideation in Menopausal Women: A Study of Korea National Health and Nutrition Examination Survey Data
Ki-Jin Ryu, Hyuntae Park, Yujin Jeong, Seunghyun Nam, Hye Gyeong Jeong, Tak Kim
|
|
| 10 |
Cost-effective BRCA Testing in Advanced Ovarian Cancer
Myungshin Kim
Ann Lab Med.2023;43(1):3-4. Published online 2022 September 1
DOI: http://dx.doi.org/10.3343/alm.2023.43.1.3
|
|
| 11 |
Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer
Jaehyeok Jang, Yoonjung Kim, Jae-Hoon Kim, Sun-Mi Cho, Kyung-A Lee
Ann Lab Med.2023;43(1):73-81. Published online 2022 September 1
DOI: http://dx.doi.org/10.3343/alm.2023.43.1.73
|
|
| 12 |
Clinical outcomes of immunohistochemistry of the p53 Staining pattern in high-grade serous ovarian carcinoma
Panarat Orachum, Amornrat Temtanakitpaisan, Pilaiwan Kleebkaow, Bandit Chumworathayi, Sanguanchoke Luanratanakorn, Apiwat Aue-angkul, Yuwadee Itarat
Obstet Gynecol Sci.2022;65(5):459-467. Published online 2022 July 29
DOI: http://dx.doi.org/10.5468/ogs.22102
|
|
| 13 |
Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee
Cancer Res Treat.2023;55(1):245-257. Published online 2022 July 19
DOI: http://dx.doi.org/10.4143/crt.2022.232
|
|
| 14 |
A modified hydrostatic microfluidic pumpless device for in vitro murine ovarian tissue culture as research model for fertility preservation
Paweena Thuwanut, Alongkorn Pimpin, Fueangrat Thatsanabunjong, Sayamon Srisuwatanasagul, Wisan Sereepapong, Porntip Sirayapiwat
Obstet Gynecol Sci.2022;65(4):376-381. Published online 2022 June 16
DOI: http://dx.doi.org/10.5468/ogs.22012
|
|
| 15 |
Multiple biomarkers are more accurate than a combination of carbohydrate antigen 125 and human epididymis protein 4 for ovarian cancer screening
Kyung Nam Kang, Eun Young Koh, Ji Young Jang, Chul Woo Kim
Obstet Gynecol Sci.2022;65(4):346-354. Published online 2022 April 21
DOI: http://dx.doi.org/10.5468/ogs.22017
|
|
| 16 |
Incidence and predictive factors for recurrent clear cell ovarian carcinoma: results from a single center in Thailand
Wikanda Hemman, Athithan Rattanaburi
Obstet Gynecol Sci.2022;65(2):188-196. Published online 2022 February 23
DOI: http://dx.doi.org/10.5468/ogs.21313
|
|
| 17 |
Ultrasonographic ovarian mass scoring system for predicting malignancy in pregnant women with ovarian mass
Se Jin Lee, Hye Rim Oh, Sunghun Na, Han Sung Hwang, Seung Mi Lee
Obstet Gynecol Sci.2022;65(1):1-13. Published online 2022 January 15
DOI: http://dx.doi.org/10.5468/ogs.21212
|
|
| 18 |
Signature of arylacetamide deacetylase expression is associated with prognosis and immune infiltration in ovarian cancer
Jianyang Feng, Hong He
Obstet Gynecol Sci.2022;65(1):52-63. Published online 2022 January 15
DOI: http://dx.doi.org/10.5468/ogs.21237
|
|
| 19 |
Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy
Aeran Seol, Ga Won Yim, Joo Yeon Chung, Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong Sang Song
Cancer Res Treat.2022;54(4):1219-1229. Published online 2021 November 17
DOI: http://dx.doi.org/10.4143/crt.2021.1010
|
|
| 20 |
Association between decreased ovarian reserve and poor oocyte quality
Viviane Margareth Scantamburlo, Renate von Linsingen, Lidio Jair Ribas Centa, Kahisa Fontana Dal Toso, Debora Scaraboto, Edward Araujo Júnior, Jaime Kulak Junior
Obstet Gynecol Sci.2021;64(6):532-539. Published online 2021 October 19
DOI: http://dx.doi.org/10.5468/ogs.20168
|
|
